About Cardihab
Cardihab is a Healthcare company based in Brisbane (Australia) founded in 2016. Digital cardiac rehabilitation solutions are developed for patients and clinicians. Cardihab has raised $1.35 million across 2 funding rounds from investors including ImpaQt Qld, Artesian and Uniseed. Its chief executive, as recorded, is Gus Taddeo. Cardihab offers products and services including Clinician Portal, Patient Apps, Virtual Care Plans, and Clinical Implementation Support. Its focus areas include HealthTech, Healthcare IT, Provider and Telemedicine Solutions. Its legal entity is Cardihab Pty Ltd. Its competitors include GP2U, Updoc and Access Telehealth; 3 of its 3 listed competitors have raised funding.
Company details
Cardihab was founded in 2016 as a spinoff from the Commonwealth Scientific and Industrial Research Organisation in Brisbane, Australia. Operations focus on health technology within the cardiac sector, where apps and a web platform are utilized to deliver virtual rehabilitation services, adherence tracking, telemedicine, and remote patient monitoring. These tools support clinicians in managing patient care remotely.
- Headquarters Brisbane, Australia
- SectorsHealthcare
- Email••••••••
- Website cardihab.com
- Social LinkedIn X
- Legal Name Cardihab Pty Ltd
- Total Equity Funding$1.35M (USD)
in 2 rounds
- InvestorsImpaQt Qld
& 3 more
Products & Services of Cardihab
Cardihab offers a comprehensive portfolio of products and services, including Clinician Portal, Patient Apps, Virtual Care Plans, and Clinical Implementation Support.
Platform for creating personalized virtual care plans.
Apps for remote recovery support from heart events.
Personalized plans based on clinical guidelines.
Training and assistance for healthcare teams.
Funding Insights of Cardihab
Cardihab has successfully raised a total of $1.35M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.35M
- Total Rounds 2
- First Round $1.35M
(Jun 2017)
- Investors Count 4
All 2 funding rounds of Cardihab with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2021 | Seed | – | ImpaQt Qld | – | |
| Jun 2017 | $1.35M | Seed | – | – |
4 investors in total: 4 institutional.
Investors in Cardihab
Cardihab has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include ImpaQt Qld, Artesian and Uniseed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| impaqtqld.com.au | ||||
Venture capital and private debt fund focused on climate, agrifood, health, AI, and multiple sectors | artesianinvest.com | Sydney, Australia | ||
Seed-stage investments are directed toward Australian companies. | uniseed.com | Brisbane, Australia | ||
Offers cardiology consultations, diagnostic tests, and heart treatments in Queensland. | 1993 | qcg.com.au | Brisbane, Australia |
Investor details for Cardihab
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cardihab
10 people are tracked at Cardihab (3 in leadership, 3 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Gus Taddeo | CEO | Leadership |
Helen Souris | CEO | Leadership |
Philip Barnes | Consulting CFO | Leadership |
John Rivers | Director | Board & advisors |
Hugh Dawkins | Director | Board & advisors |
Melissa Mail | Director | Board & advisors |
Duncan Ion | Product Lead | Team |
Rebecca Burton | Strategic Advisor | Team |
Maha Khalaf | Executive Assistant | Team |
George Lambrou | Business Development Manager | Team |
Complete people profiles for Cardihab
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cardihab
3 dated milestones of Cardihab across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Cardihab is founded.
- Funding First funding round of $1.4M.
- Funding Latest funding round, Seed,.
Competitors of Cardihab
Cardihab has 3 listed competitors in our database, 3 of them funded. They include GP2U, Updoc and Access Telehealth.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gp2u.com.au | 2011 | Hobart, Australia | $2.2M | Appointment booking Video consultation platform for patients | ||
| updoc.com.au | 2020 | Sydney, Australia | $13.29M | Updoc is recognized as a telehealth platform in Australia. | ||
| accesstelehealth.com.au | 2016 | Elsternwick, Australia | $12.5M | Telehealth platform is provided for patients and healthcare professionals. |
Detailed competitors of Cardihab
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cardihab
The website of Cardihab (cardihab.com) receives about 1K visits a month.
- Monthly visits1K
▲ 240.3% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cardihab
Cardihab was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Cardihab is headquartered in Brisbane, Australia. It is registered at Brisbane, Queensland, Australia.
Gus Taddeo is the CEO of Cardihab, as recorded in our data.
Cardihab is a funded company, having raised a total of $1.35M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.35M, raised on Jun 2017.
Cardihab was founded in 2016 as a spinoff from the Commonwealth Scientific and Industrial Research Organisation in Brisbane, Australia. Operations focus on health technology within the cardiac sector, where apps and a web platform are utilized to deliver virtual rehabilitation services, adherence tracking, telemedicine, and remote patient monitoring. These tools support clinicians in managing patient care remotely.
Cardihab's top competitors include GP2U, Updoc and Access Telehealth.
Cardihab offers Clinician Portal, Patient Apps, Virtual Care Plans, and Clinical Implementation Support.
Cardihab has 4 investors. Key investors include ImpaQt Qld, Artesian, Uniseed, and Queensland Cardiovascular Group.
Cardihab operates through Cardihab Pty Ltd.